Events

Loading Events

« All Events

  • This event has passed.

American Academy of Neurology (AAN) 2017

April 22, 2017 - April 28, 2017


Simulations Plus will be presenting the following posters.

Physiologically- Based and Population Pharmacokinetic Modeling and Simulation to Support Dose Selection and Study Design for Eslicarbazepine Acetate (ESL) Adjunctive Therapy in Infants with Partial Onset Seizures (POS ).

Authors: Soujanya Sunkaraneni,1 Sebastien Bihorel (Associate Director, Pharmacometrics),2 Elizabeth Ludwig (Executive Director, Clinical Pharmacology, Pharmacometric Services),2 Jill Fiedler-Kelly (Vice President, Pharmacometric Services, PK/PD),2 Denise Morris (Assistant Director, Clinical Pharmacology),2 Seth Hopkins,1 Gerald Galluppi,1 David Blum1.

1Sunovion Pharmaceuticals Inc., Marlborough, MA, USA; 2Cognigen Corporation, a SimulationsPlus company, Buffalo, NY, USA.

Modeling and Simulation Strategy to Support Eslicarbazepine Acetate (ESL) Pediatric Dose Selection in the Treatment of Partial Onset Seizures Based on Matching Adult Exposures

Authors: Soujanya Sunkaraneni,1 Sebastien Bihorel (Associate Director, Pharmacometrics),2 Elizabeth Ludwig (Executive Director, Clinical Pharmacology, Pharmacometric Services),2 Jill Fiedler-Kelly (Vice President, Pharmacometric Services, PK/PD), 2 Seth Hopkins,1 Gerald Galluppi,1 David Blum1.

1Sunovion Pharmaceuticals Inc., Marlborough, MA, USA; 2Cognigen Corporation, a SimulationsPlus company, Buffalo, NY, USA.

Boston Convention and Exhibition Center
415 Summer St
Boston, MA 02210, United States

https://www.aan.com/conferences/2017-annual-meeting/

Details

Start:
April 22, 2017
End:
April 28, 2017
Website:
https://www.aan.com/conferences/2017-annual-meeting/

Venue

Boston Convention and Exhibition Center
415 Summer St
Boston, MA 02210 United States
+ Google Map
Phone:
(617) 954-2000
Website:
https://massconvention.com/

In Case You Missed A Recent Webinar or Product Video:

MembranePlus™ v2 webinar: Stimulate your kinetic understanding…

Use of oral absorption modelling to characterize drug release and absorption of a BCS II compound from IR formulations